The Epidemiology and Economics of Chronic Back Pain
慢性背痛的流行病学和经济学
基本信息
- 批准号:9314938
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAdverse eventAffectAgeBack PainBusinessesCaringCessation of lifeCharacteristicsChronicComorbidityConsumptionDataDatabasesDecision AnalysisDevelopmentDiagnosisDoctor of PhilosophyEconomic PolicyEconomicsEducational process of instructingEffectivenessElderlyEnvironmentEpidemiologyExpenditureFundingGoalsHealthHealth Care CostsHealth PolicyHealth StatusHealthcareIncidenceInjection of therapeutic agentLearningLiteratureLow Back PainMeasuresMedicalMedicareMedicare claimMedicineMentorsMissionMorbidity - disease rateNational Institute of Drug AbuseNeck PainOpioidPainPain ResearchPain managementPatientsPhysiciansPoliciesPopulationPositioning AttributePrevalencePrivatizationProductivityProviderPsychologyPublic HealthRadiculitisRadiculopathyResearchResearch InfrastructureResearch PersonnelRiskRisk FactorsSchoolsSciaticaScienceServicesSteroidsTherapeutic procedureTrainingTreatment EffectivenessUnited StatesUniversitiesUse EffectivenessVertebral columnVisitWagesWorkaddictionalternative treatmentcareerchronic back painchronic painclinical decision-makingclinically relevantcostcost effectivecost effectivenesscost-effectiveness evaluationeconomic costeffective therapyexperiencehealth economicsimprovedinnovationinterestmedical specialtiesmortalitymultidisciplinaryolder patientopioid abuseopioid usepaymentprogramstool
项目摘要
Project Summary. Low back pain imposes a high burden in terms of morbidity and healthcare spending.
From a policy standpoint, there are two important issues. First, many patients with low back pain ultimately
transition into chronic opioid use, with its resulting effects on mortality, morbidity, and healthcare spending.
Second, the cost-effectiveness of many treatments for low back pain has not been fully characterized. The
long-term goal of this project are to (1) characterize the economics and epidemiology of chronic opioid use
among patients with low back pain, (2) evaluate whether therapeutic procedures (such as epidural steroid
injections) reduce opioid use and healthcare spending, and (3) evaluate the cost-effectiveness of alternative
treatments for low back pain. Accomplishing these goals will inform policymakers and payers about the
epidemiology and economics of low back pain, and improve policymaking, for example by helping to guide
payment policies for low back pain treatments. For this particular application, the objectives are to use
administrative health claims data from Medicare to: (1) characterize opioid use trajectories in elderly patients
with low back pain as well as patient/provider factors that affect these trajectories, (2) analyze the effectiveness
of Epidural Steroid Injections (ESIs) in reducing opioid use and healthcare spending among these patients and
(3) analyze the cost-effectiveness of Epidural Steroid Injections. This research is innovative in its use of large
databases and sophisticated statistical approaches to provide definitive answers to the questions described
above. It is significant because of its comprehensive approach towards addressing several policy- and
clinically-relevant questions of compelling interest and of interest to the NIDA. In addition to the research
objectives outlined above, this project will also allow the candidate to achieve his long-term goal of becoming
an independent investigator in health economics/policy with a particular focus on the economics of chronic pain.
Specifically, the project will aid the candidate’s development by (1) increasing his experience and background
in pain research, addiction medicine, and non-pharmacologic pain treatments and (2) giving the primary
investigator the didactic training and experience needed to perform cost-effectiveness studies using tools from
decision science. The project leverage the strengths of Stanford University, such as a multidisciplinary
mentoring team uniquely tailored to the candidate’s interests and background. In addition, it takes advantage
of an existing PhD program in Health Policy (with a specific track in decision science) to provide the didactic
training and practical experience the candidate requires in order to learn decision science and transition into a
career as an independent investigator. With this training and experience, the candidate will be uniquely
positioned to use tools from his prior background in economics, as well as the tools of decision science, to
seek further funding that will evaluate the effectiveness of other treatments—as well as policies in general--in
reducing opioid use and treating chronic pain.
项目摘要。腰痛在发病率和医疗保健支出方面造成了很大的负担。
从政策角度看,有两个重要问题。首先,许多腰痛患者最终
过渡到慢性阿片类药物使用,其对死亡率,发病率和医疗保健支出的影响。
其次,许多治疗腰痛的成本效益尚未完全确定。的
该项目的长期目标是(1)描述慢性阿片类药物使用的经济学和流行病学特征
在腰痛患者中,(2)评估治疗程序(如硬膜外类固醇)是否
注射)减少阿片类药物的使用和医疗保健支出,(3)评估替代药物的成本效益
治疗腰痛。实现这些目标将使政策制定者和支付者了解
腰痛的流行病学和经济学,并改善政策制定,例如通过帮助指导
下背痛治疗的支付政策。对于这个特定的应用程序,目标是使用
医疗保险的行政健康索赔数据:(1)描述老年患者的阿片类药物使用轨迹
下背痛以及影响这些轨迹的患者/提供者因素,(2)分析有效性
硬膜外类固醇注射(ESI)在减少这些患者的阿片类药物使用和医疗保健支出方面的作用,
(3)分析硬膜外类固醇注射的成本效益。这项研究是创新的,在其使用大
数据库和复杂的统计方法,为所描述的问题提供明确的答案
以上它之所以重要,是因为它采取了全面的办法来处理若干政策问题,
临床相关的问题,令人信服的利益和利益的NIDA。除了研究
除了上述目标外,该项目还将使候选人实现其成为
卫生经济学/政策的独立调查员,特别关注慢性疼痛的经济学。
具体来说,该项目将通过(1)增加他的经验和背景来帮助候选人的发展
疼痛研究,成瘾医学和非药物疼痛治疗;(2)给予主要的
调查员使用以下工具进行成本效益研究所需的教学培训和经验:
决策科学该项目利用了斯坦福大学的优势,如多学科
根据候选人的兴趣和背景量身定制的辅导团队。此外,它还利用
现有的健康政策博士课程(在决策科学的特定轨道),以提供教学
培训和实践经验,候选人需要学习决策科学和过渡到一个
作为一名独立调查员。有了这些培训和经验,候选人将是独一无二的
定位于使用他以前的经济学背景工具,以及决策科学工具,
寻求进一步的资金,以评估其他治疗方法以及一般政策的有效性,
减少阿片类药物的使用和治疗慢性疼痛。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Sun其他文献
Eric Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Sun', 18)}}的其他基金
The Epidemiology and Economics of Chronic Back Pain
慢性背痛的流行病学和经济学
- 批准号:
9979811 - 财政年份:2017
- 资助金额:
$ 19.5万 - 项目类别:
The Epidemiology and Economics of Chronic Back Pain
慢性背痛的流行病学和经济学
- 批准号:
10305586 - 财政年份:2017
- 资助金额:
$ 19.5万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Discovery Grants Program - Individual